Ariela Noy, MD

Hematologic Oncologist

Conditions Treated:

Ariela Noy, MD

About Me

I am a board-certified hematologist and medical oncologist with a major focus on treating cancers of the lymphoid immune system, in particular lymphomas and certain forms of leukemia. HIV-related lymphomas are one my main areas of interest. To provide the best treatment to each patient with these diseases, I work very closely with a team of expert specialists.

Read more

My research interests include HIV-related cancers, especially lymphoma; molecular detection of minimal disease in patients on lymphoma trials; and a variety of other lymphoma-related projects, including new treatments, imaging, and quality of life.

At a national level, I serve as the chair of the Lymphoma Working Group for the AIDS Malignancy consortium, an NCI sponsored research group. I serve on two NIH committees that oversee the national lymphoma research agenda. I also review for a number of journals. At Memorial Sloan Kettering I am a member of the Department of Medicine Quality Assurance, Minimal Residual Disease in Hematology, and Fertility Preservation Committees.

In addition, I enjoy my role as a mentor to students from the high school to postgraduate level.

  • Clinical Expertise: Hodgkin and Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Castleman's Disease, AIDS-related cancers
  • Languages Spoken: English
  • Education: MD, University of Pennsylvania School of Medicine
  • Residencies: Columbia-Presbyterian Medical Center
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Hematology; Medical Oncology

Appointments Available

Making an appointment

Call 646-497-9137

See My Colleagues

Publications

Visit PubMed for a full listing of Ariela Noy’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.